How do you justify, measure and scale investments?
AI is rapidly moving from experimentation to enterprise-wide adoption, creating new opportunities to improve productivity, reduce costs, accelerate decision-making and mitigate risk. However, as AI investments grow, organizations must develop clear frameworks for measuring business value, prioritizing initiatives and supporting resources that are allocated to the highest-impact opportunities.
This workshop explores the economics of enterprise AI, including tokenization costs, hard-dollar ROI, value realization and portfolio-level governance. Participants will examine practical approaches for scaling successful pilots into production programs while measuring outcomes across R&D, Clinical, Regulatory, Manufacturing, Quality and Commercial functions. The session will focus on helping leaders connect AI investments to measurable business results and sustainable organizational value.
Key takeaways
Join fellow Life Sciences, business, data and AI leaders for an interactive discussion on how to measure, justify and scale AI investments that deliver meaningful business outcomes. As organizations move beyond experimentation, success increasingly depends on understanding the economics of AI, identifying the highest-value opportunities and establishing frameworks that connect AI initiatives to measurable operational and financial results.
Learn how leading organizations evaluate hard-dollar ROI, manage tokenization and operational costs, prioritize investments and scale successful AI programs from pilot to enterprise adoption. Discuss practical approaches for value realization, portfolio-level governance and performance measurement across R&D, Clinical, Regulatory, Manufacturing, Quality and Commercial functions, supporting AI investments that generate sustainable business impact.